Pharmaceutical

A missed opportunity for GS1 to explain why India’s bar...

A recent essay in Express Pharma by Mr. S. Swaminathan, CEO of GS1 India, extol...

ERS Genomics and Sai Life Sciences sign CRISPR/Cas9 lic...

ERS Genomics Limited (‘ERS’), the CRISPR licensing company, announced that it h...

SIRO Clintech reloaded 

Corporate history is replete with examples of the ‘third generation curse’, but...

EC approves Menarini and NewAmsterdam’s obicetrapib the...

The authorisation allows both treatments to be used for patients with primary hy...

Made Scientific acquires cell therapy facility in Penns...

The company said programmes could be onboarded at the facility immediately, rath...

GCF organises three day conference on ‘Advancing green ...

The pharmaceutical industry is increasingly focusing on integrating Green and S...

BDR Pharmaceuticals International appoints Niral Bhatt ...

BDR Pharmaceuticals International Pvt Ltd has announced the appointment of Nira...

India’s biotech self-reliance moment 

For much of the past two decades, global biotech leadership has clustered aroun...

Lex Witness announces 12th Annual Pharmaceutical Legal ...

Like previous editions, the Summit will focus on practical perspectives, peer l...

Andelyn Biosciences begins commercial manufacturing of ...

Andelyn Biosciences, a leading and patient-focused cell and gene therapy Contra...

Telix to acquire ITM in deal worth up to $2.35bn

The Australian company will pay $1.65bn upfront on a cash-free, debt-free basis....

Sandoz and mAbxience agree on emicizumab biosimilar par...

The candidate is in early-stage development and references Hemlibra (emicizumab)...

How pharma is charting a greener path to growth 

The conversation around environmental sustainability in the pharma industry is ...

Akums announces DCGI-approved triple therapy for H. pyl...

Akums Drugs & Pharmaceuticals has announced the development of a DCGI-approved ...

Biocon receives EMA CHMP approval for Pertuzumab biosim...

Biocon Biologics announced that the Committee for Medicinal Products for Human ...

Why pharma needs smarter decision-making, not just more...

The pharmaceutical industry has invested heavily in digitisation over the past f...